| Ireland | 001-37757 | 98-1328821 | ||||||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) | ||||||
|
3 Dublin Landings, North Wall Quay
Dublin 1, Ireland D01 H104
| ||
| (Address of principal executive offices) | ||
| Title of class | Trading symbol(s) | Name of exchange on which registered | ||||||||||||
| Ordinary Shares, par value $0.001 | ADNT | New York Stock Exchange | ||||||||||||
| EXHIBIT INDEX | ||||||||
| Exhibit No. | Exhibit Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document). |
|||||||
| ADIENT PLC | ||||||||
| Date: February 7, 2023 | By: | /s/ Heather M. Tiltmann | ||||||
| Name: | Heather M. Tiltmann | |||||||
| Title: | Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary |
|||||||




| Three Months Ended December 31, |
||||||||||||||
| (in millions, except per share data) | 2022 | 2021 | ||||||||||||
| Net sales | $ | 3,699 | $ | 3,480 | ||||||||||
| Cost of sales | 3,468 | 3,307 | ||||||||||||
| Gross profit | 231 | 173 | ||||||||||||
| Selling, general and administrative expenses | 138 | 162 | ||||||||||||
| Restructuring and impairment costs | 7 | 4 | ||||||||||||
| Equity income (loss) | 28 | 33 | ||||||||||||
| Earnings (loss) before interest and income taxes | 114 | 40 | ||||||||||||
| Net financing charges | 41 | 50 | ||||||||||||
| Other pension expense (income) | 9 | (1) | ||||||||||||
| Income (loss) before income taxes | 64 | (9) | ||||||||||||
| Income tax provision (benefit) | 31 | 21 | ||||||||||||
| Net income (loss) | 33 | (30) | ||||||||||||
| Income attributable to noncontrolling interests | 21 | 24 | ||||||||||||
| Net income (loss) attributable to Adient | $ | 12 | $ | (54) | ||||||||||
| Diluted earnings (loss) per share | $ | 0.13 | $ | (0.57) | ||||||||||
| Shares outstanding at period end | 95.4 | 94.8 | ||||||||||||
| Diluted weighted average shares | 95.9 | 94.6 | ||||||||||||
| December 31, | September 30, | |||||||||||||
| (in millions) | 2022 | 2022 | ||||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 901 | $ | 947 | ||||||||||
Accounts receivable - net |
1,755 | 1,852 | ||||||||||||
| Inventories | 972 | 953 | ||||||||||||
| Other current assets | 459 | 411 | ||||||||||||
| Current assets | 4,087 | 4,163 | ||||||||||||
| Property, plant and equipment - net | 1,419 | 1,377 | ||||||||||||
| Goodwill | 2,128 | 2,057 | ||||||||||||
| Other intangible assets - net | 463 | 467 | ||||||||||||
| Investments in partially-owned affiliates | 306 | 286 | ||||||||||||
| Assets held for sale | 5 | 11 | ||||||||||||
| Other noncurrent assets | 865 | 797 | ||||||||||||
| Total assets | $ | 9,273 | $ | 9,158 | ||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||
| Short-term debt | $ | 13 | $ | 14 | ||||||||||
| Accounts payable and accrued expenses | 2,736 | 2,818 | ||||||||||||
| Other current liabilities | 669 | 669 | ||||||||||||
| Current liabilities | 3,418 | 3,501 | ||||||||||||
| Long-term debt | 2,627 | 2,564 | ||||||||||||
| Other noncurrent liabilities | 674 | 673 | ||||||||||||
| Redeemable noncontrolling interests | 45 | 45 | ||||||||||||
| Shareholders' equity attributable to Adient | 2,192 | 2,073 | ||||||||||||
| Noncontrolling interests | 317 | 302 | ||||||||||||
| Total liabilities and shareholders' equity | $ | 9,273 | $ | 9,158 | ||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Operating Activities | ||||||||||||||
| Net income (loss) attributable to Adient | $ | 12 | $ | (54) | ||||||||||
| Income attributable to noncontrolling interests | 21 | 24 | ||||||||||||
| Net income (loss) | 33 | (30) | ||||||||||||
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | ||||||||||||||
| Depreciation | 69 | 75 | ||||||||||||
| Amortization of intangibles | 12 | 13 | ||||||||||||
| Pension and postretirement benefit expense (benefit) | 9 | 1 | ||||||||||||
| Pension and postretirement contributions, net | (3) | (5) | ||||||||||||
| Equity in earnings of partially-owned affiliates, net of dividends received | (16) | (32) | ||||||||||||
| Derivative loss on the 2021 Yanfeng Transaction | — | 3 | ||||||||||||
| Deferred income taxes | (1) | (3) | ||||||||||||
| Non-cash restructuring and impairment charges | — | 7 | ||||||||||||
| Equity-based compensation | 8 | 10 | ||||||||||||
| Other | (3) | 2 | ||||||||||||
| Changes in assets and liabilities: | ||||||||||||||
| Receivables | 167 | (175) | ||||||||||||
| Inventories | 22 | 26 | ||||||||||||
| Other assets | (47) | — | ||||||||||||
| Restructuring reserves | (27) | (24) | ||||||||||||
| Accounts payable and accrued liabilities | (191) | 104 | ||||||||||||
| Accrued income taxes | 12 | 14 | ||||||||||||
| Cash provided (used) by operating activities | 44 | (14) | ||||||||||||
| Investing Activities | ||||||||||||||
| Capital expenditures | (61) | (60) | ||||||||||||
| Sale of property, plant and equipment | 15 | 11 | ||||||||||||
| Settlement of derivatives | — | (30) | ||||||||||||
| Business acquisitions | (6) | — | ||||||||||||
| Proceeds from business divestitures | 3 | 731 | ||||||||||||
| Other | (1) | — | ||||||||||||
| Cash provided (used) by investing activities | (50) | 652 | ||||||||||||
| Financing Activities | ||||||||||||||
| Increase (decrease) in short-term debt | — | (6) | ||||||||||||
| Increase (decrease) in long-term debt | 2 | — | ||||||||||||
| Repayment of long-term debt | (2) | (2) | ||||||||||||
| Debt financing costs | (7) | — | ||||||||||||
| Dividends paid to noncontrolling interests | (50) | (59) | ||||||||||||
| Share based compensation and other | (12) | (12) | ||||||||||||
| Cash provided (used) by financing activities | (69) | (79) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 29 | — | ||||||||||||
| Increase (decrease) in cash and cash equivalents | $ | (46) | $ | 559 | ||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Net Sales | ||||||||||||||
| Americas | $ | 1,724 | $ | 1,498 | ||||||||||
| EMEA | 1,182 | 1,230 | ||||||||||||
| Asia | 821 | 784 | ||||||||||||
| Eliminations | (28) | (32) | ||||||||||||
| Total net sales | $ | 3,699 | $ | 3,480 | ||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Adjusted EBITDA | ||||||||||||||
| Americas | $ | 69 | $ | 9 | ||||||||||
| EMEA | 28 | 43 | ||||||||||||
| Asia | 138 | 114 | ||||||||||||
Corporate-related costs (1) |
(23) | (20) | ||||||||||||
Restructuring and impairment costs (2) |
(7) | (4) | ||||||||||||
Purchase accounting amortization (3) |
(12) | (14) | ||||||||||||
Restructuring related charges (4) |
(3) | (1) | ||||||||||||
Adjustment to nonconsolidated partially-owned affiliates (8) |
1 | — | ||||||||||||
| Stock based compensation | (8) | (10) | ||||||||||||
| Depreciation | (69) | (75) | ||||||||||||
Other items (5) |
— | (2) | ||||||||||||
| Earnings (loss) before interest and income taxes | 114 | 40 | ||||||||||||
| Net financing charges | (41) | (50) | ||||||||||||
| Other pension income (expense) | (9) | 1 | ||||||||||||
| Income (loss) before income taxes | $ | 64 | $ | (9) | ||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions, except per share data) | 2022 | 2021 | ||||||||||||
| Income available to shareholders | ||||||||||||||
| Net income (loss) attributable to Adient | $ | 12 | $ | (54) | ||||||||||
| Weighted average shares outstanding | ||||||||||||||
| Basic weighted average shares outstanding | 95.1 | 94.6 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Stock options, unvested restricted stock and unvested performance share awards | 0.8 | — | ||||||||||||
| Diluted weighted average shares outstanding | 95.9 | 94.6 | ||||||||||||
| • | Adjusted EBIT is defined as income before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. | ||||
| • | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and stock based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. Adjusted EBITDA excluding adjusted equity income, each as defined herein, is also presented. | ||||
| • | Adjusted net income attributable to Adient is defined as net income attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, expenses associated with becoming an independent company, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. | ||||
| • | Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. | ||||
| • | Adjusted earnings per share is defined as Adjusted net income attributable to Adient divided by diluted weighted average shares. | ||||
| • | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or one-time items impacting equity income. | ||||
| • | Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense. | ||||
| • | Free cash flow is defined as cash provided by operating activities less capital expenditures. | ||||
| • | Net debt is calculated as gross debt (short-term and long-term) less cash and cash equivalents. | ||||
| Three Months Ended December 31, | ||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | |||||||||||||||||||||||||||||||||||||
| (in millions, except per share data) | GAAP Results | Adj. | Adjusted Results | GAAP Results | Adj. | Adjusted Results | ||||||||||||||||||||||||||||||||
| Net sales | $ | 3,699 | $ | — | $ | 3,699 | $ | 3,480 | $ | — | $ | 3,480 | ||||||||||||||||||||||||||
Cost of sales (6) |
3,468 | (1) | 3,467 | 3,307 | (1) | 3,306 | ||||||||||||||||||||||||||||||||
| Gross profit | 231 | 1 | 232 | 173 | 1 | 174 | ||||||||||||||||||||||||||||||||
Selling, general and administrative expenses (7) |
138 | (14) | 124 | 162 | (15) | 147 | ||||||||||||||||||||||||||||||||
Restructuring and impairment costs (2) |
7 | (7) | — | 4 | (4) | — | ||||||||||||||||||||||||||||||||
Equity income (loss) (8) |
28 | (1) | 27 | 33 | 1 | 34 | ||||||||||||||||||||||||||||||||
| Earnings (loss) before interest and income taxes (EBIT) | 114 | 21 | 135 | 40 | 21 | 61 | ||||||||||||||||||||||||||||||||
| Memo accounts: | ||||||||||||||||||||||||||||||||||||||
| Depreciation | 69 | 75 | ||||||||||||||||||||||||||||||||||||
| Equity based compensation | 8 | 10 | ||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 212 | $ | 146 | ||||||||||||||||||||||||||||||||||
Net financing charges (9) |
41 | — | 41 | 50 | (3) | 47 | ||||||||||||||||||||||||||||||||
Other pension expense (income) (12) |
9 | (8) | 1 | (1) | — | (1) | ||||||||||||||||||||||||||||||||
| Income (loss) before income taxes | 64 | 29 | 93 | (9) | 24 | 15 | ||||||||||||||||||||||||||||||||
Income tax provision (benefit) (10) |
31 | 6 | 37 | 21 | 4 | 25 | ||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Adient | 12 | 21 | 33 | (54) | 18 | (36) | ||||||||||||||||||||||||||||||||
| Diluted earnings (loss) per share | 0.13 | 0.21 | 0.34 | (0.57) | 0.19 | (0.38) | ||||||||||||||||||||||||||||||||
| Diluted weighted average shares | 95.9 | — | 95.9 | 94.6 | — | 94.6 | ||||||||||||||||||||||||||||||||
| Three months ended December 31, 2022 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,724 | $ | 1,182 | $ | 821 | $ | (28) | $ | 3,699 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 69 | $ | 28 | $ | 138 | $ | (23) | $ | 212 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 4.0 | % | 2.4 | % | 16.8 | % | N/A | 5.7 | % | |||||||||||||||||||||||
| Three months ended December 31, 2021 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,498 | $ | 1,230 | $ | 784 | $ | (32) | $ | 3,480 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 9 | $ | 43 | $ | 114 | $ | (20) | $ | 146 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 0.6 | % | 3.5 | % | 14.5 | % | N/A | 4.2 | % | |||||||||||||||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Adjusted EBITDA | $ | 212 | $ | 146 | ||||||||||
| Adjusted Equity Income | 27 | 34 | ||||||||||||
| Adjusted EBITDA Excluding Adjusted Equity Income | $ | 185 | $ | 112 | ||||||||||
| % of Sales | 5.0 | % | 3.2 | % | ||||||||||
| Three months ended December 31, | ||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | |||||||||||||||||||||||||||||||||||||
| (in millions, except effective tax rate) | Income (loss) before income taxes | Tax impact | Effective tax rate | Income (loss) before income taxes | Tax impact | Effective tax rate | ||||||||||||||||||||||||||||||||
| As reported | $ | 64 | $ | 31 | 48.4% | $ | (9) | $ | 21 | nm | ||||||||||||||||||||||||||||
Adjustments (10) |
29 | 6 | 20.7% | 24 | 4 | 16.7% | ||||||||||||||||||||||||||||||||
| As adjusted | $ | 93 | $ | 37 | 39.8% | $ | 15 | $ | 25 | nm | ||||||||||||||||||||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Net income (loss) attributable to Adient | 12 | (54) | ||||||||||||
Restructuring and impairment costs |
7 | 4 | ||||||||||||
Purchase accounting amortization (3) |
12 | 14 | ||||||||||||
Restructuring related charges |
3 | 1 | ||||||||||||
Pension mark-to-market and curtailment/settlement (gain)/loss (12) |
8 | — | ||||||||||||
Adjustment to nonconsolidated partially-owned affiliates (8) |
(1) | — | ||||||||||||
Derivative loss on Yanfeng transaction (9) |
— | 3 | ||||||||||||
Other items (5) |
— | 2 | ||||||||||||
Impact of adjustments on noncontrolling interests (11) |
(2) | (2) | ||||||||||||
Tax impact of above adjustments and other tax items (10) |
(6) | (4) | ||||||||||||
| Adjusted net income (loss) attributable to Adient | $ | 33 | $ | (36) | ||||||||||
| Three Months Ended December 31, |
||||||||||||||
| 2022 | 2021 | |||||||||||||
| Diluted earnings (loss) per share as reported | $ | 0.13 | $ | (0.57) | ||||||||||
| Restructuring and impairment costs | 0.07 | 0.04 | ||||||||||||
Purchase accounting amortization (3) |
0.12 | 0.15 | ||||||||||||
| Restructuring related charges | 0.03 | 0.01 | ||||||||||||
Pension mark-to-market and curtailment/settlement (gain)/loss (12) |
0.08 | — | ||||||||||||
Adjustment to nonconsolidated partially-owned affiliates (8) |
(0.01) | — | ||||||||||||
Derivative loss on Yanfeng transaction (9) |
— | 0.03 | ||||||||||||
Other items (5) |
— | 0.02 | ||||||||||||
Impact of adjustments on noncontrolling interests (11) |
(0.02) | (0.02) | ||||||||||||
Tax impact of above adjustments and other tax items (10) |
(0.06) | (0.04) | ||||||||||||
| Adjusted diluted earnings (loss) per share | $ | 0.34 | $ | (0.38) | ||||||||||
| June 30, | September 30, | |||||||||||||
| (in millions) | 2022 | 2022 | ||||||||||||
| Cash and cash equivalents | $ | 901 | $ | 947 | ||||||||||
| Total short-term and long-term debt | 2,640 | 2,578 | ||||||||||||
| Net debt | $ | 1,739 | $ | 1,631 | ||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Cash provided (used) by operating activities | $ | 44 | $ | (14) | ||||||||||
| Capital expenditures | (61) | (60) | ||||||||||||
| Free cash flow | $ | (17) | $ | (74) | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Adjusted EBITDA excluding adjusted equity income | $ | 185 | $ | 112 | ||||||||||
| (+) Dividend | 12 | 2 | ||||||||||||
| (-) Restructuring (cash) | (30) | (24) | ||||||||||||
| (+/-) Net customer tooling | (14) | 2 | ||||||||||||
| (+/-) Trade working capital (Net AR/AP + Inventory) | 46 | 75 | ||||||||||||
| (+/-) Accrued compensation | (28) | (61) | ||||||||||||
| (-) Interest paid | (24) | (41) | ||||||||||||
| (+/-) Tax refund/taxes paid | (20) | (8) | ||||||||||||
| (+/-) Non-income related taxes (VAT) | (19) | 36 | ||||||||||||
| (+/-) Commercial settlements | (17) | (54) | ||||||||||||
| (+/-) Capitalized engineering | (25) | (5) | ||||||||||||
| (+/-) Prepaids | (24) | (23) | ||||||||||||
| (+/-) Other | 2 | (25) | ||||||||||||
| Operating cash flow | 44 | (14) | ||||||||||||
| Capital expenditures | (61) | (60) | ||||||||||||
| Free cash flow | $ | (17) | $ | (74) | ||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Restructuring charges | $ | (7) | $ | 3 | ||||||||||
| Held for sale asset adjustments | — | (7) | ||||||||||||
| $ | (7) | $ | (4) | |||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Transaction costs | $ | (1) | $ | (2) | ||||||||||
| Brazil indirect tax recoveries | 1 | 1 | ||||||||||||
| Other | — | (1) | ||||||||||||
| $ | — | $ | (2) | |||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Restructuring related charges | $ | (2) | $ | (1) | ||||||||||
| Brazil indirect tax recoveries | 1 | 1 | ||||||||||||
| Other | — | (1) | ||||||||||||
| $ | (1) | $ | (1) | |||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Purchase accounting amortization | $ | (12) | $ | (13) | ||||||||||
| Transaction costs | (1) | (2) | ||||||||||||
| Restructuring related charges | (1) | — | ||||||||||||
| $ | (14) | $ | (15) | |||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Adjustment to nonconsolidated partially-owned affiliates | $ | (1) | $ | — | ||||||||||
| Purchase accounting amortization | — | 1 | ||||||||||||
| $ | (1) | $ | 1 | |||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Derivative loss on Yanfeng transaction | $ | — | $ | (3) | ||||||||||
| $ | — | $ | (3) | |||||||||||
| Three Months Ended December 31, |
||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Pension curtailment loss | $ | (2) | $ | — | ||||||||||
| Brazil indirect tax recoveries | — | (3) | ||||||||||||
Amortization |
(2) | (2) | ||||||||||||
| Other reconciling items | (2) | 1 | ||||||||||||
| $ | (6) | $ | (4) | |||||||||||